P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 12.89 CNY -0.54% Market Closed
Market Cap: 4.4B CNY
Have any thoughts about
Pulike Biological Engineering Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Pulike Biological Engineering Inc

Current Assets 1.2B
Cash & Short-Term Investments 508.5m
Receivables 468.9m
Other Current Assets 213.8m
Non-Current Assets 1.9B
Long-Term Investments 353.5m
PP&E 1.2B
Intangibles 293.8m
Other Non-Current Assets 38.3m
Current Liabilities 441m
Accounts Payable 103.9m
Accrued Liabilities 37.5m
Short-Term Debt 31.8m
Other Current Liabilities 267.8m
Non-Current Liabilities 36.4m
Long-Term Debt 1.1m
Other Non-Current Liabilities 35.3m

Balance Sheet
Pulike Biological Engineering Inc

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
214
391
429
250
438
283
240
165
282
312
Cash
0
0
0
0
0
0
0
165
282
312
Cash Equivalents
213
391
429
250
438
283
240
0
0
0
Short-Term Investments
0
400
515
700
295
319
266
75
691
408
Total Receivables
122
112
118
115
150
169
215
310
507
490
Accounts Receivables
78
109
103
109
141
129
205
292
482
439
Other Receivables
44
3
15
7
9
40
10
18
25
51
Inventory
53
60
62
71
97
118
134
171
192
184
Other Current Assets
4
3
2
15
23
23
25
14
22
17
Total Current Assets
392
966
1 125
1 152
1 003
912
880
733
1 683
1 409
PP&E Net
324
299
353
369
367
395
466
652
950
1 175
PP&E Gross
324
299
353
369
367
395
466
652
950
1 175
Accumulated Depreciation
114
140
163
192
223
285
302
324
375
447
Intangible Assets
115
231
215
208
220
220
223
276
286
283
Goodwill
0
0
0
0
0
18
18
18
18
18
Long-Term Investments
6
7
42
59
290
321
391
418
383
340
Other Long-Term Assets
1
1
2
18
23
40
52
71
75
37
Other Assets
0
0
0
0
0
18
18
18
18
18
Total Assets
838
N/A
1 504
+80%
1 737
+16%
1 805
+4%
1 903
+5%
1 906
+0%
2 029
+6%
2 168
+7%
3 396
+57%
3 262
-4%
Liabilities
Accounts Payable
31
21
28
29
43
39
45
49
123
110
Accrued Liabilities
9
13
19
27
37
43
52
60
70
69
Short-Term Debt
0
0
0
0
0
0
0
0
55
35
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
1
1
Other Current Liabilities
86
108
177
151
158
132
193
237
307
294
Total Current Liabilities
126
142
224
207
238
214
290
346
556
508
Long-Term Debt
0
0
0
0
0
0
0
0
2
1
Deferred Income Tax
0
0
0
0
2
7
11
15
25
8
Other Liabilities
29
24
32
30
28
27
18
7
8
22
Total Liabilities
154
N/A
167
+8%
256
+54%
236
-8%
268
+13%
247
-8%
319
+29%
368
+15%
592
+61%
538
-9%
Equity
Common Stock
120
160
324
324
324
322
322
321
353
353
Retained Earnings
511
604
744
794
865
888
1 053
1 139
1 239
1 188
Additional Paid In Capital
53
573
459
478
474
449
469
473
1 346
1 324
Treasury Stock
0
0
46
27
27
0
134
134
134
141
Total Equity
684
N/A
1 337
+96%
1 481
+11%
1 569
+6%
1 636
+4%
1 658
+1%
1 710
+3%
1 800
+5%
2 804
+56%
2 724
-3%
Total Liabilities & Equity
838
N/A
1 504
+80%
1 737
+16%
1 805
+4%
1 903
+5%
1 906
+0%
2 029
+6%
2 168
+7%
3 396
+57%
3 262
-4%
Shares Outstanding
Common Shares Outstanding
240
320
320
324
324
322
322
315
346
346

See Also

Discover More